These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16045424)

  • 1. Patients' values and clinical substituted judgments: the case of localized prostate cancer.
    Elstein AS; Chapman GB; Knight SJ
    Health Psychol; 2005 Jul; 24(4S):S85-92. PubMed ID: 16045424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agreement between prostate cancer patients and their clinicians about utilities and attribute importance.
    Elstein AS; Chapman GB; Chmiel JS; Knight SJ; Chan C; Nadler RB; Kuzel TM; Siston AK; Bennett CL
    Health Expect; 2004 Jun; 7(2):115-25. PubMed ID: 15117386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of perspectives on prostate cancer: analysis of utility assessments of patients and physicians.
    Bennett CL; Chapman G; Elstein AS; Knight SJ; Nadler RB; Sharifi R; Kuzel T
    Eur Urol; 1997; 32 Suppl 3():86-8. PubMed ID: 9267792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-attribute model of prostate cancer patient's preferences for health states.
    Chapman GB; Elstein AS; Kuzel TM; Nadler RB; Sharifi R; Bennett CL
    Qual Life Res; 1999 May; 8(3):171-80. PubMed ID: 10472149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shared decision making: prostate cancer patients' appraisal of treatment alternatives and oncologists' eliciting and responding behavior, an explorative study.
    Pieterse AH; Henselmans I; de Haes HC; Koning CC; Geijsen ED; Smets EM
    Patient Educ Couns; 2011 Dec; 85(3):e251-9. PubMed ID: 21658883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient preferences in prostate cancer: a clinician's guide to understanding health utilities.
    Kramer KM; Bennett CL; Pickard AS; Lyons EA; Wolf MS; McKoy JM; Knight SJ
    Clin Prostate Cancer; 2005 Jun; 4(1):15-23. PubMed ID: 15992457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experiences of randomization: interviews with patients and clinicians in the SPCG-IV trial.
    Bill-Axelson A; Christensson A; Carlsson M; Norlén BJ; Holmberg L
    Scand J Urol Nephrol; 2008; 42(4):358-63. PubMed ID: 19230168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel computer based expert decision making model for prostate cancer disease management.
    Richman MB; Forman EH; Bayazit Y; Einstein DB; Resnick MI; Stovsky MD
    J Urol; 2005 Dec; 174(6):2310-8. PubMed ID: 16280831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Controversial guidelines in early diagnosis of prostate cancer].
    Casal ER; Majdalani MP
    Medicina (B Aires); 2003; 63(1):77-81. PubMed ID: 12673967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current decision-making in prostate cancer therapy.
    Cox J; Amling CL
    Curr Opin Urol; 2008 May; 18(3):275-8. PubMed ID: 18382237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating a decision aid for patients with localized prostate cancer in clinical practice.
    Isebaert S; Van Audenhove C; Haustermans K; Junius S; Joniau S; De Ridder K; Van Poppel H
    Urol Int; 2008; 81(4):383-8. PubMed ID: 19077396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A trial for comparing methods for eliciting treatment preferences from men with advanced prostate cancer: results from the initial visit.
    Souchek J; Stacks JR; Brody B; Ashton CM; Giesler RB; Byrne MM; Cook K; Geraci JM; Wray NP
    Med Care; 2000 Oct; 38(10):1040-50. PubMed ID: 11021677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituted judgment in principle and practice: a national physician survey.
    Combs MP; Rasinski KA; Yoon JD; Curlin FA
    Mayo Clin Proc; 2013 Jul; 88(7):666-73. PubMed ID: 23809317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a utility weighting function for the patient-oriented prostate utility scale (PORPUS).
    Tomlinson G; Bremner KE; Ritvo P; Naglie G; Krahn MD
    Med Decis Making; 2012; 32(1):11-30. PubMed ID: 21653804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer.
    Zeliadt SB; Ramsey SD; Penson DF; Hall IJ; Ekwueme DU; Stroud L; Lee JW
    Cancer; 2006 May; 106(9):1865-74. PubMed ID: 16568450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One man's tough choices on prostate cancer.
    Alexander T
    Fortune; 1993 Sep; 128(6):86-8, 90, 92 passim. PubMed ID: 10129683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer.
    Zeliadt SB; Penson DF; Moinpour CM; Blough DK; Fedorenko CR; Hall IJ; Smith JL; Ekwueme DU; Thompson IM; Keane TE; Ramsey SD
    BJU Int; 2011 Sep; 108(6):851-6; discussion 856-7. PubMed ID: 21244609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparatory education for informed decision-making in prostate cancer early detection and treatment.
    Myers RE; Kunkel EJ
    Semin Urol Oncol; 2000 Aug; 18(3):172-7. PubMed ID: 10975487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Navigating healthcare: a qualitative study exploring prostate cancer patients' and doctors' experience of consultations using a decision-support intervention.
    Hacking B; Scott SE; Wallace LM; Shepherd SC; Belkora J
    Psychooncology; 2014 Jun; 23(6):665-71. PubMed ID: 24677394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCA: prostate cancer, patient-centred approach or both?
    Denis L; Joniau S; Bossi A; Baskin-Bey E; Fitzpatrick JM
    BJU Int; 2012 Jul; 110(1):16-22. PubMed ID: 22233268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.